Episode 247 | Stan Glezer, Managing Director at Outcome Capital | Strategic Transactions in MedTech: Insights & Advice episode artwork

EPISODE · Feb 2, 2026 · 39 MIN

Episode 247 | Stan Glezer, Managing Director at Outcome Capital | Strategic Transactions in MedTech: Insights & Advice

from Project Medtech · host Project Medtech

In this episode, Duane Mancini sits down with Stan Glezer, Managing Director at Outcome Capital, to dive deep into the roles of strategic advisory and investment banking in driving innovation within the life sciences sector. Stan elaborates on his multifaceted career, from his beginnings as a physician to leading roles in biopharma and MedTech companies. He discusses the importance of aligning a company's value proposition with market dynamics, the art and science behind M&A deals, and why realistic, transparent goals can unlock transactional success. Stan Glezer LinkedInOutcome Capital WebsiteDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

Episode metadata supplied by the publisher feed · Published Feb 2, 2026

Embed this episode

NOW PLAYING

Episode 247 | Stan Glezer, Managing Director at Outcome Capital | Strategic Transactions in MedTech: Insights & Advice

0:00 39:19

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 39 minutes long.

When was this Project Medtech episode published?

This episode was published on February 2, 2026.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!